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SELF-ASSESSMENT QUESTIONS
1. Which of the following is a proven risk factor for invasive amebiasis?
A. Being female
B. HIV infection
C. Inﬂammatory bowel disease
D. Prolonged antibiotic use
E. Travel to or residence in an area of endemicity
Answer: E. The predominant risk factors for amebiasis include travel to or
residence in areas of endemicity, being poor, being a man who has sex with men
(MSM), being institutionalized, pregnancy, immunosuppression (including corti-
costeroids), alcoholism, malignancy, and malnutrition. Being male is associated
with a higher risk of amebic liver abscess but not amebic dysentery. An associ-
ation between MSM status and amebiasis is likely to relate to potential feco-oral
exposure during sexual contact. Attempts to associate HIV and amebiasis have
been confounded by high proportions of MSM within HIV populations. There is
no known association between invasive amebiasis and prolonged antibiotic use
or inﬂammatory bowel disease, apart from associated therapy with systemic or
rectal steroids.
2. What is the most commonly used serological assay in the diagnosis of amebiasis?
A. Complement ﬁxation
B. ELISA (enzyme-linked immunosorbent assay)
C. IFA (indirect ﬂuorescent assay)
D. Immunochromatographic lateral-ﬂow assay
E. Latex agglutination
Answer: B. ELISA is the most common assay used in diagnostic laboratories, as
it is easily reproducible. It can be useful in the diagnosis of intestinal and
extraintestinal amebic infections when amebiasis is suspected. IFA has the added
CitationWingﬁeld T, Ball R, Woolley SD,
Campbell F, Heath RM, Beeching NJ, Turtle L.
2018. Closing the Brief Case: A rare case of
invasive amebiasis requiring emergency
subtotal colectomy in an HIV-positive man. J
Clin Microbiol 56:e01704-17. https://doi.org/10
.1128/JCM.01704-17.
Editor Carey-Ann D. Burnham, Washington
University School of Medicine
Copyright © 2018 American Society for
Microbiology. All Rights Reserved.
Address correspondence to Lance Turtle,
lance.turtle@liverpool.ac.uk.
R.B., S.D.W., and F.C. contributed equally as
second authors.
See https://doi.org/10.1128/JCM.01703-17 in this
issue for case presentation and discussion.
THE BRIEF CASE
crossm
August 2018 Volume 56 Issue 8 e01704-17 jcm.asm.org 1Journal of Clinical Microbiology
 o
n






advantage over ELISA in being able to distinguish between previous and current
infections, and IFA IgM levels can be used to monitor the effect of treatment of
invasive amebiasis. IFA is reported to have a sensitivity of 93.6% and a speciﬁcity
of 96.7%, which is reported as being better than those of ELISA. IFA is more
technically challenging to perform and usually performed in more specialized
laboratories.
3. Which of the following is an appropriate treatment regimen for invasive amebi-
asis?
A. Ceftriaxone and metronidazole
B. Metronidazole or tinidazole
C. Paromomycin or diloxanide furoate
D. Metronidazole or tinidazole and paromomycin or diloxanide furoate
E. Co-trimoxazole
Answer: D. The aims of treatment of amebiasis are to eliminate invasive tropho-
zoites (using either metronidazole or tinidazole) and to eradicate carriage of E.
histolytica cysts in the intestine (using a luminal agent such as paromomycin or
diloxanide furoate). Treating trophozoites and not cysts or vice versa would not
be adequate. There is no routine need for antibacterial agents in the treatment
of invasive amebiasis unless there are other indications, such as colonic perfo-
ration, as in the reported case. Co-trimoxazole can be used in diarrheal disease
caused by Cyclospora cayetanensis or Cystoisospora belli but is not indicated for
invasive amebiasis.
TAKE-HOME POINTS
● Consider amebiasis in the differential diagnosis of patients presenting with
diarrhea who have traveled to an area of endemicity, even when exposure time
is limited.
● Serological tests for amebiasis include ELISA and IFA, with ELISA being more
commonly used but IFA having greater sensitivity and speciﬁcity and the
advantages of being able to support differentiation of previous versus current
amebiasis and to monitor response to treatment.
● Treatment of amebiasis requires elimination of invasive trophozoites with
metronidazole and tinidazole, followed by eradication of luminal cysts with
paromomycin or diloxanide furoate.
● MSM are at risk from invasive amebiasis, and attempts to associate HIV and
amebiasis have been confounded by high proportions of MSM within HIV
populations.
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